الفهرس | Only 14 pages are availabe for public view |
Abstract Background: Caesarean section is a common surgical procedure in the field of obstetrics. Caesarean section rate is increasing worldwide. Postoperative pain is a common undesirable outcome following caesarean section. Proper post-caesarean section patients’ management should target management of pain as well as early mobilization, reduction of side effects to the mother and the newborn, rapid functional recovery, and early discharge. Inadequate control of post-caesarean section pain can lead to an increased risk of thromboembolic events, delayed breastfeeding, and post-partum depression. Aim of the Work: The aim of this study is to assess the efficacy and safety of adding Magnesium Sulfate as an adjuvant to Bupivacaine in ultrasound guided TAP block in reducing post-caesarean section pain in women undergoing elective caesarean section. Patients and Methods: 92 adult patients undergoing caesarean section under spinal anesthesia were randomly allocated to one of 2 groups (n=46; each). group A patients received ultrasound-guided transversus abdominis plane (TAP) block using 20 mL of 0.25% Bupivacaine (10 mL Bupivacaine 0.5% + 10 mL normal saline) bilaterally at the end of operation directly after skin closure. group B patients received ultrasound guided TAP block using 20 mL of 0.25% Bupivacaine with Magnesium Sulfate (10 mL Bupivacaine 0.5% + 2 mL Magnesium Sulfate 10% (200 mg) + 8 mL normal saline) bilaterally. Conclusion: Addition of Magnesium Sulfate to Bupivacaine used in TAP block following caesarean section enhances its efficacy and prolongs its duration of action which can ultimately lead to reduction in post-operative analgesics consumption, increased patient safety, early patient functional recovery and better surgical outcomes. |